These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 12939656

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertension.
    Gazzaruso C, Buscaglia P, Garzaniti A, Bonetti G, Savino S, Mariotti S, Jucci A, Finardi G, Geroldi D.
    J Cardiovasc Risk; 1996 Apr; 3(2):191-7. PubMed ID: 8836862
    [Abstract] [Full Text] [Related]

  • 3. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate.
    Rader DJ, Cain W, Ikewaki K, Talley G, Zech LA, Usher D, Brewer HB.
    J Clin Invest; 1994 Jun; 93(6):2758-63. PubMed ID: 8201014
    [Abstract] [Full Text] [Related]

  • 4. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
    Dieplinger H, Lackner C, Kronenberg F, Sandholzer C, Lhotta K, Hoppichler F, Graf H, König P.
    J Clin Invest; 1993 Feb; 91(2):397-401. PubMed ID: 8432847
    [Abstract] [Full Text] [Related]

  • 5. Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus.
    Peros E, Geroldi D, Bugatti S, Caporali R, Rossi P, Montecucco C, D'Angelo A, Emanuele E.
    Int J Mol Med; 2005 Apr; 15(4):661-5. PubMed ID: 15754029
    [Abstract] [Full Text] [Related]

  • 6. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
    Milionis HJ, Elisaf MS, Tselepis A, Bairaktari E, Karabina SA, Siamopoulos KC.
    Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Determination of lipoprotein(a) concentrations and apolipoprotein(a) molecular weights in diabetic patients.
    Ribault A, Durou MR, Letellier C, Wojcik F, Poirier JY, Ruelland A.
    Diabetes Metab; 2000 Apr; 26(2):107-12. PubMed ID: 10804324
    [Abstract] [Full Text] [Related]

  • 9. Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation.
    Becker L, Cook PM, Koschinsky ML.
    Biochemistry; 2004 Aug 10; 43(31):9978-88. PubMed ID: 15287725
    [Abstract] [Full Text] [Related]

  • 10. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
    Kimak E, Solski J.
    Ren Fail; 2002 Mar 10; 24(2):187-95. PubMed ID: 12071592
    [Abstract] [Full Text] [Related]

  • 11. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
    Longenecker JC, Klag MJ, Marcovina SM, Liu YM, Jaar BG, Powe NR, Fink NE, Levey AS, Coresh J.
    J Am Soc Nephrol; 2005 Jun 10; 16(6):1794-802. PubMed ID: 15800123
    [Abstract] [Full Text] [Related]

  • 12. Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients.
    Wanner C, Bartens W, Walz G, Nauck M, Schollmeyer P.
    Nephrol Dial Transplant; 1995 Jun 10; 10(1):75-81. PubMed ID: 7724034
    [Abstract] [Full Text] [Related]

  • 13. Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease.
    Peros E, Geroldi D, D'Angelo A, Falcone C, Montagna L, Carabela M, Emanuele E.
    Int J Mol Med; 2004 Feb 10; 13(2):243-7. PubMed ID: 14719130
    [Abstract] [Full Text] [Related]

  • 14. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine.
    Milionis HJ, Efstathiadou Z, Tselepis AD, Bairaktari ET, Tsironis LD, Tsatsoulis A, Elisaf MS.
    Thyroid; 2003 Apr 10; 13(4):365-9. PubMed ID: 12804105
    [Abstract] [Full Text] [Related]

  • 15. Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1).
    Dieplinger H, Kronenberg F.
    Wien Klin Wochenschr; 1999 Jan 15; 111(1):5-20. PubMed ID: 10067265
    [Abstract] [Full Text] [Related]

  • 16. [Study of lipoprotein (a) phenotypes in Ivorian subject].
    Tiahou G, Aveynier E, Djessou P, Sess D, Cristol JP.
    Bull Soc Pathol Exot; 2005 Jun 15; 98(2):99-103. PubMed ID: 16050374
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production.
    Rader DJ, Cain W, Zech LA, Usher D, Brewer HB.
    J Clin Invest; 1993 Feb 15; 91(2):443-7. PubMed ID: 8432853
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of apolipoprotein(a) isoform size heterogeneity on the lysine binding function of lipoprotein(a) in early onset coronary artery disease.
    Simó JM, Joven J, Vilella E, Ribas M, Pujana MA, Sundaram IM, Hammel JP, Hoover-Plow JL.
    Thromb Haemost; 2001 Mar 15; 85(3):412-7. PubMed ID: 11307806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.